Dr. Eva E. Redei conducts research in the following categories: depressive disorders, biomarkers for depression, stress hypersensitivity, biomarkers for stress-reactivity, genetic vulnerability to depression and to hypersensitivity to stress, epigenetic regulation, imprinted genes, neuroendocrinology of the hypothalamic-pituitary-thyroid and hypothalamic-pituitary-adrenal axes.
She has an MS in Chemical Engineering from the Budapest University of Technology and Economics, and a PhD in Organic Chemistry from the Eotvos Lorand University, Budapest, Hungary. She was a postdoctoral fellow at the Brain Research Institute, UCLA, Los Angeles, CA.
Most Recent Publications
Redei EE, Andrus BM, Kwasny MJ, Seok J, Cai X, Ho J, Mohr DC. Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy. Translational Psychiatry. 2014 May 8;4:doi:10.1038/tp.2014.66. ISSN: 21583188
Williams KA, Mehta NS, Redei EE, Wang L, Procissi D. Aberrant resting-state functional connectivity in a genetic rat model of depression. Psychiatry Research – Neuroimaging. 2014 Apr 30;222(1-2):111-113. doi:10.1016/j.pscychresns. 2014.02.001.PMID: 24613017 ISSN: 09254927
Tunc-Ozcan E, Sittig LJ, Harper KM, Graf EN, Redei EE. Hypothesis: Genetic and epigenetic risk factors interact to modulate vulnerability and resilience to FASDFrontiers in Genetics. 2014 Jan;5(AUG):doi:10.3389/fgene.2014.00261. ISSN: 16648021
Sittig LJ and Redei EE: Fine-Tuning Notes in the Behavioral Symphony: Parent-of-Origin Allelic Gene Expression in the Brain. Advances in Genetics 2014; 86, 93-106.
Pajer K, Andrus BM, Gardner W, Lourie A, Strange B, Campo J, Bridge J, Blizinsky K, Dennis K, Vedell P, Churchill G, Redei EE. Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early onset major depression Translational Psychiatry 2, e101; doi:10.1038/tp.2012.26, 2012.